| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $31.76B | +1.1% |
| Cost of Revenue | $11.40B | +13.7% |
| Gross Profit | $20.36B | -4.7% |
| R&D Expense | $642.0M | +4.1% |
| Operating Income | $12.25B | -5.6% |
| Interest Expense | $768.0M | +4.2% |
| Pre-tax Income | $11.63B | -4.9% |
| Income Tax | $2.24B | -16.0% |
| Net Income | $9.05B |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.21B | -28.7% |
| Accounts Receivable | $3.85B | +23.3% |
| Inventory | $9.89B | +13.4% |
| Current Assets | $19.62B | +10.7% |
| Total Assets | $61.68B | +49.4% |
| Current Liabilities | $27.34B | +42.0% |
| Long-term Debt | $34.88B | +40.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $10.80B | -9.7% |
| Capital Expenditures | $1.08B | +44.0% |
| Investing Cash Flow | -$15.68B | -564.9% |
| Financing Cash Flow | $3.81B | +131.8% |
| Free Cash Flow | $9.73B | -13.3% |
| -0.7% |
| EPS (Basic) | $5.82 | -0.2% |
| EPS (Diluted) | $5.81 | -0.3% |
| Total Liabilities |
| $67.99B |
| +37.4% |
| Stockholders' Equity | -$8.96B | +11.4% |